GenoME Diagnostics Ltd
PrivateLast Round
Grant
Mar 6, 2023
Total Funding Raised
$2.73M
Company Overview
GenoME Diagnostics Ltd is a biotechnology company that develops blood-based diagnostic tests for the early detection and monitoring of cancer using a proprietary DNA methylation and fragmentomic platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenoME Diagnostics Ltd Comparables
Compare GenoME Diagnostics Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CpG Diagnostics, Inc. | 85% | |
| EarlyDiagnostics | 81% | |
| Exai Bio | 80% |
GenoME Diagnostics Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 6, 2023 | ||||
| Seed | Mar 6, 2023 | ||||
| Seed | May 25, 2021 |
Key People
Founding team and executive leadership
GenoME Diagnostics Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QUBIS | Seed |
| Innovate UK | Grant |
| Clarendon Fund Managers | Seed |
| Deepbridge Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
Monthly visitors increased 36% MoM.
- Jun 1, 2025
Monthly visitors increased 31% MoM.
GenoME Diagnostics Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GenoME Diagnostics Ltd's valuation, stock price, and market status.
Is GenoME Diagnostics Ltd a public or private company?
GenoME Diagnostics Ltd is a private company.
What is the current stock price of GenoME Diagnostics Ltd?
GenoME Diagnostics Ltd is a private company with no public stock price. Caplight tracks GenoME Diagnostics Ltd's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is GenoME Diagnostics Ltd worth (valuation)?
Valuation information for GenoME Diagnostics Ltd is not publicly available.
Can I buy GenoME Diagnostics Ltd stock?
GenoME Diagnostics Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GenoME Diagnostics Ltd's last funding round?
GenoME Diagnostics Ltd's most recent funding round was Grant on March 6, 2023.
Who are the main investors in GenoME Diagnostics Ltd?
Key investors in GenoME Diagnostics Ltd include QUBIS, Innovate UK, Clarendon Fund Managers, Deepbridge Capital.
Will GenoME Diagnostics Ltd IPO soon?
No public IPO plans have been announced for GenoME Diagnostics Ltd.
How can I track GenoME Diagnostics Ltd secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenoME Diagnostics Ltd's secondary market activity and sign up for updates.